Effect of age on second messenger generation in neutrophils.

Abstract:

:Neutrophils from healthy elderly donors generate significantly less diacylglycerol (DAG) and inositol triphosphate (IP3) than neutrophils from young donors, following stimulation by the chemotactic peptide, formyl-methionyl-leucylphenylalanine (FMLP). The defect in signal transduction occurred at a point proximal to the generation of IP3 and DAG, since the reduction in FMLP-induced superoxide generation was corrected if the intervening signal transduction steps were bypassed, either by priming with a substimulatory dose (1.62 nmol/L) of phorbol myristate acetate (PMA), by ionophore elevation of cytosolic calcium, or by using a stimulatory dose of PMA (1.62 mumol/L). FMLP receptor number and affinity were unaffected by aging. On FMLP activation, neutrophils from old, as compared with young, volunteers showed significantly greater and more long-lasting decreases in the concentrations of phosphatidylinositol (PI), phosphatidylinositol 4-monophosphate (PIP), and phosphatidylinositol 4,5-bisphosphate (PIP2). This indicates a reduction with age in the metabolically active precursor pools responsible for the generation of IP3 and DAG. In contrast, aging had little effect on the production of phosphatidic acid (PA), which has recently been suggested to serve as a major activator of the NADPH oxidase. This may explain why the decrease in IP3 and DAG production was not accompanied by a comparable decrement in superoxide generation, which was only 17% lower in the old than in young donor neutrophils. Thus, aging is associated with reductions in the concentration of critically important phosphoinositides, resulting in diminution in the ability to produce key second messengers. Although the aged neutrophil is largely able to compensate for the decrements in signal transduction, its reserve capacity is compromised, making it particularly vulnerable to external insults that also impair function.

journal_name

Blood

journal_title

Blood

authors

Lipschitz DA,Udupa KB,Indelicato SR,Das M

subject

Has Abstract

pub_date

1991-09-01 00:00:00

pages

1347-54

issue

5

eissn

0006-4971

issn

1528-0020

journal_volume

78

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway.

    abstract::Platelets play a crucial role in the physiology of primary hemostasis and pathophysiologic processes such as arterial thrombosis. Accumulating evidence suggests a role of reactive oxygen species (ROSs) in platelet activation. Here we show that platelets activated with different agonists produced intracellular ROSs, wh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-03-1047

    authors: Begonja AJ,Gambaryan S,Geiger J,Aktas B,Pozgajova M,Nieswandt B,Walter U

    更新日期:2005-10-15 00:00:00

  • Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays.

    abstract::The ability to transfer new genetic material into human hematopoietic cells provides the foundation for characterizing the organization and developmental program of human hematopoietic stem cells. It also provides a valuable model in which to test gene transfer and long-term expression in human hematopoietic cells as ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dick JE,Kamel-Reid S,Murdoch B,Doedens M

    更新日期:1991-08-01 00:00:00

  • A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.

    abstract::Idiopathic pneumonia syndrome (IPS) is a major complication after allogeneic bone marrow transplantation (allo-BMT) and involves the infiltration of donor leukocytes and the secretion of inflammatory cytokines. We hypothesized that leukocyte recruitment during IPS is dependent in part upon interactions between chemoki...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2708

    authors: Hildebrandt GC,Duffner UA,Olkiewicz KM,Corrion LA,Willmarth NE,Williams DL,Clouthier SG,Hogaboam CM,Reddy PR,Moore BB,Kuziel WA,Liu C,Yanik G,Cooke KR

    更新日期:2004-03-15 00:00:00

  • Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab.

    abstract::The anti-CD20 antibody rituximab depletes human B cells from peripheral blood, but it remains controversial to what extent tissue-resident B cells are affected. In representative patients with rheumatoid arthritis, we here demonstrate that recently activated presumably short-lived plasmablasts expressing HLA-DR(high) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-266536

    authors: Mei HE,Frölich D,Giesecke C,Loddenkemper C,Reiter K,Schmidt S,Feist E,Daridon C,Tony HP,Radbruch A,Dörner T

    更新日期:2010-12-09 00:00:00

  • Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

    abstract::The FOXP1 forkhead transcription factor is targeted by recurrent chromosome translocations in several subtypes of B-cell non-Hodgkin lymphomas, where high-level FOXP1 protein expression has been linked to a poor prognosis. Western blotting studies of diffuse large B-cell lymphoma (DLBCL) cell lines unexpectedly identi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-115113

    authors: Brown PJ,Ashe SL,Leich E,Burek C,Barrans S,Fenton JA,Jack AS,Pulford K,Rosenwald A,Banham AH

    更新日期:2008-03-01 00:00:00

  • Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.

    abstract::The human immunodeficiency virus (HIV) causes impairment of the immune system in part by targeting CD4(+) T cells for infection and dysfunction. HIV envelope (Env) present on free virions and infected cells causes dysfunction of uninfected bystander CD4(+) T cells via interaction with both CD4 and coreceptors. Env is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-038661

    authors: Fernando K,Hu H,Ni H,Hoxie JA,Weissman D

    更新日期:2007-03-15 00:00:00

  • The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

    abstract::The functions of the alphaC domains of fibrinogen in clotting and fibrinolysis, which have long been enigmatic, were determined using recombinant fibrinogen truncated at Aalpha chain residue 251. Scanning electron microscopy and confocal microscopy revealed that the fibers of alpha251 clots were thinner and denser, wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2150

    authors: Collet JP,Moen JL,Veklich YI,Gorkun OV,Lord ST,Montalescot G,Weisel JW

    更新日期:2005-12-01 00:00:00

  • T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.

    abstract::In diffuse large B-cell lymphoma (DLBCL), the number of circulating monocytes and neutrophils represents an independent prognostic factor. These cell subsets include monocytic and granulocytic myeloid-derived suppressor cells (M- and G-MDSCs) defined by their ability to suppress T-cell responses. MDSCs are a heterogen...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2015-08-662783

    authors: Azzaoui I,Uhel F,Rossille D,Pangault C,Dulong J,Le Priol J,Lamy T,Houot R,Le Gouill S,Cartron G,Godmer P,Bouabdallah K,Milpied N,Damaj G,Tarte K,Fest T,Roussel M

    更新日期:2016-08-25 00:00:00

  • Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

    abstract::Treatment of AL amyloidosis patients with high-dose melphalan chemotherapy followed by autologous peripheral blood stem cell transplantation (HDM/SCT) can produce hematologic complete responses (CRs) and improvement in organ function. To determine whether these responses are accompanied by improvement in quality of li...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-01-0089

    authors: Seldin DC,Anderson JJ,Sanchorawala V,Malek K,Wright DG,Quillen K,Finn KT,Berk JL,Dember LM,Falk RH,Skinner M

    更新日期:2004-09-15 00:00:00

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) is characterized by abnormal megakaryopoiesis and enhanced thrombotic risk. Once-daily low-dose aspirin is the recommended antithrombotic regimen, but accelerated platelet generation may reduce the duration of platelet cyclooxygenase-1 (COX-1) inhibition. We performed a multicenter doubl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004596

    authors: Rocca B,Tosetto A,Betti S,Soldati D,Petrucci G,Rossi E,Timillero A,Cavalca V,Porro B,Iurlo A,Cattaneo D,Bucelli C,Dragani A,Di Ianni M,Ranalli P,Palandri F,Vianelli N,Beggiato E,Lanzarone G,Ruggeri M,Carli G,Ell

    更新日期:2020-07-09 00:00:00

  • Activity and specificity of toxin-related mouse T cell ecto-ADP-ribosyltransferase ART2.2 depends on its association with lipid rafts.

    abstract::Adenosine diphosphate (ADP)-ribosyl-transferases (ARTs) transfer ADP-ribose from nicotinamide adenine dinucleotide (NAD) onto target proteins. T cells express ART2.2, a toxin-related, glycosylphosphatidylinositol (GPI)-anchored ecto-enzyme. After the release of NAD from cells, ART2.2 ADP-ribosylates the P2X7 purinocep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-08-3325

    authors: Bannas P,Adriouch S,Kahl S,Braasch F,Haag F,Koch-Nolte F

    更新日期:2005-05-01 00:00:00

  • Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.

    abstract::Loss or mutation of the TP53 tumor suppressor gene is not commonly observed in acute myeloid leukemia (AML), suggesting that there is an alternate route for cell transformation. We investigated the hypothesis that previously observed Bcl-2 family member overexpression suppresses wild-type p53 activity in AML. We demon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-004234

    authors: Irish JM,Anensen N,Hovland R,Skavland J,Børresen-Dale AL,Bruserud O,Nolan GP,Gjertsen BT

    更新日期:2007-03-15 00:00:00

  • Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

    abstract::Autologous hematopoietic cell transplant (AHCT) for HIV-infected patients is largely limited to centers with HIV-specific expertise. The Blood and Marrow Transplant Clinical Trials Network 0803/AIDS Malignancy Consortium 071 trial is a multicenter phase 2 study of AHCT for patients with HIV-related lymphoma (HRL). Eli...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2015-08-664706

    authors: Alvarnas JC,Le Rademacher J,Wang Y,Little RF,Akpek G,Ayala E,Devine S,Baiocchi R,Lozanski G,Kaplan L,Noy A,Popat U,Hsu J,Morris LE Jr,Thompson J,Horowitz MM,Mendizabal A,Levine A,Krishnan A,Forman SJ,Navarro WH,

    更新日期:2016-08-25 00:00:00

  • Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

    abstract::There is now strong experimental evidence that tissue factor pathway inhibitor (TFPI) is a critical inhibitor to modulate tissue factor-induced coagulation, but the role of TFPI as a risk factor for thrombosis is yet to be to be determined. This study investigated the role of low TFPI levels for the development of dee...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3188

    authors: Dahm A,Van Hylckama Vlieg A,Bendz B,Rosendaal F,Bertina RM,Sandset PM

    更新日期:2003-06-01 00:00:00

  • Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production.

    abstract::The regulation of megakaryocytopoiesis and thrombopoiesis appears to be under the control of an array of hematopoietic growth factors. To determine the relationship of endogenous thrombopoietic cytokine levels and circulating platelet (PLT) counts, we measured the levels of thrombo-poietin (TPO), interleukin-11 (IL-11...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chang M,Suen Y,Meng G,Buzby JS,Bussel J,Shen V,van de Ven C,Cairo MS

    更新日期:1996-11-01 00:00:00

  • Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies.

    abstract::Purified human high-mol-wt kininogen (HMWK), the cofactor of the contact phase of blood coagulation, migrated as a single band (approximately 110,000 mol wt) in a continuous buffer sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), but appeared as two separated bands (approximately 120,000 and 105,0...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berrettini M,Lämmle B,White T,Heeb MJ,Schwarz HP,Zuraw B,Curd J,Griffin JH

    更新日期:1986-08-01 00:00:00

  • Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.

    abstract::TLRs expressed on dendritic cells (DCs) differentially activate DCs when activated alone or in combination, inducing distinct cytokines and costimulatory molecules that influence T-cell responses. Defining the requirements of DCs to program T cells during priming to become memory rather than effector cells could enhan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-317966

    authors: Pufnock JS,Cigal M,Rolczynski LS,Andersen-Nissen E,Wolfl M,McElrath MJ,Greenberg PD

    更新日期:2011-06-16 00:00:00

  • Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib.

    abstract::The Bernard-Soulier syndrome is an inherited bleeding disorder that is due to a deficiency in platelet glycoprotein Ib. Bernard-Soulier platelets fail to agglutinate in response to ristocetin despite normal levels of factor VIII:von Willebrand factor. We report a patient who developed severe refractory thrombocytopeni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Devine DV,Currie MS,Rosse WF,Greenberg CS

    更新日期:1987-08-01 00:00:00

  • Inhibitory receptors specific for MHC class I educate murine NK cells but not CD8αα intestinal intraepithelial T lymphocytes.

    abstract::The engagement of inhibitory receptors specific for major histocompatibility complex class I (MHC-I) molecules educates natural killer (NK) cells, meaning the improvement of the response of activation receptors to subsequent stimulation. It is not known whether inhibitory MHC-I receptors educate only NK cells or wheth...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-331124

    authors: Taveirne S,Filtjens J,Van Ammel E,De Colvenaer V,Kerre T,Taghon T,Vandekerckhove B,Plum J,Held W,Leclercq G

    更新日期:2011-07-14 00:00:00

  • Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa.

    abstract::Human B-cell lines were derived by limiting dilutions of Epstein-Barr virus (EBV) transformed peripheral B cells from a patient with an autoantibody against glycoprotein (GP)Ia/IIa, and manifesting defective collagen-induced platelet aggregation and a bleeding problem. Antibody-producing clones were selected for their...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deckmyn H,Zhang J,Van Houtte E,Vermylen J

    更新日期:1994-09-15 00:00:00

  • Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

    abstract::Endothelial progenitor cell (EPC) mobilization has been reported following tissue damage, whereas no data are available regarding the mobilization of hematopoietic progenitor cells (HPCs). We performed the phenotypic and functional analysis of circulating CD34+ progenitor cells in patients with acute myocardial infarc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-1831

    authors: Massa M,Rosti V,Ferrario M,Campanelli R,Ramajoli I,Rosso R,De Ferrari GM,Ferlini M,Goffredo L,Bertoletti A,Klersy C,Pecci A,Moratti R,Tavazzi L

    更新日期:2005-01-01 00:00:00

  • Development of T3/T cell receptor gene expression in human pre-T neoplasms.

    abstract::Acquisition of mature T cell function and the T cell antigen receptor repertoire occur in the thymus. In an effort to delineate the cascade of events leading to T cell maturation, we analyzed a series of clonal human precursor T cell neoplasms representing early, middle, and late stages of intrathymic differentiation....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pittaluga S,Uppenkamp M,Cossman J

    更新日期:1987-04-01 00:00:00

  • In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.

    abstract::Recent findings implied that the progression of hematologic malignancies, like that of solid tumors, is dependent on neovascularization. Recent studies on patients with acute myeloid leukemia (AML) showed increased levels of leukocyte-associated vascular endothelial growth factor (VEGF) and neovascularization of the b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.V100.13.4622

    authors: Schuch G,Machluf M,Bartsch G Jr,Nomi M,Richard H,Atala A,Soker S

    更新日期:2002-12-15 00:00:00

  • Quantifying the development of the peripheral naive CD4+ T-cell pool in humans.

    abstract::What are the rules that govern a naive T cell's prospects for survival or division after export from the thymus into the periphery? To help address these questions, we combine data from existing studies with robust mathematical models to estimate the absolute contributions of thymopoiesis, peripheral division, and los...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-184184

    authors: Bains I,Antia R,Callard R,Yates AJ

    更新日期:2009-05-28 00:00:00

  • 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

    abstract::In an attempt to improve outcomes for patients with acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT), we conducted a phase 1/2 study in which targeted irradiation delivered by 131I-anti-CD45 antibody was combined with targeted busulfan (BU; area-under-curve, 600-900 ng/mL) and cyc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2317

    authors: Pagel JM,Appelbaum FR,Eary JF,Rajendran J,Fisher DR,Gooley T,Ruffner K,Nemecek E,Sickle E,Durack L,Carreras J,Horowitz MM,Press OW,Gopal AK,Martin PJ,Bernstein ID,Matthews DC

    更新日期:2006-03-01 00:00:00

  • Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.

    abstract::Zosuquidar, which modulates P-glycoprotein (P-gp) with minimal delay of anthracycline clearance, may reverse P-gp-mediated resistance in acute myeloid leukemia without increased toxicity. A total of 449 adults older than 60 years with acute myeloid leukemia or high-risk myelodysplastic syndrome enrolled in a randomize...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-04-277269

    authors: Cripe LD,Uno H,Paietta EM,Litzow MR,Ketterling RP,Bennett JM,Rowe JM,Lazarus HM,Luger S,Tallman MS

    更新日期:2010-11-18 00:00:00

  • Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

    abstract::Dasatinib is a BCR-ABL inhibitor with 325-fold higher potency than imatinib against unmutated BCR-ABL in vitro. Imatinib failure is commonly caused by BCR-ABL mutations. Here, dasatinib efficacy was analyzed in patients recruited to phase 2/3 trials with chronic-phase chronic myeloid leukemia with or without BCR-ABL m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-214221

    authors: Müller MC,Cortes JE,Kim DW,Druker BJ,Erben P,Pasquini R,Branford S,Hughes TP,Radich JP,Ploughman L,Mukhopadhyay J,Hochhaus A

    更新日期:2009-12-03 00:00:00

  • The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model.

    abstract::Pulmonary arterial hypertension (PAH) is suspected to be a strong mortality determinant of hemolytic disorders. However, direct contribution of acute intravascular hemolysis to fatal PAH has not been investigated. The roles of nitric oxide (NO) insufficiency and platelet activation in hemolysis-associated fatal PAH ha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-267112

    authors: Hu W,Jin R,Zhang J,You T,Peng Z,Ge X,Bronson RT,Halperin JA,Loscalzo J,Qin X

    更新日期:2010-09-02 00:00:00

  • CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6.

    abstract::Regulated adherence of polymorphonuclear leukocytes (PMNs) to endothelium and subendothelial matrix is a critical event for PMN localization at and migration into inflammatory sites. We previously reported that human PMNs stimulated in vitro adhere to laminin, the major glycoprotein of mammalian basement membrane, by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bohnsack JF

    更新日期:1992-03-15 00:00:00

  • Demonstration and mode of action of an inhibitor for activated Hageman factor (factor XIIa) of the intrinsic blood coagulation pathway from Schistosoma mansoni.

    abstract::An anticoagulant activity from adult Schistosoma mansoni whole worm homogenate is described. The inhibitor appears to be specific for the contact activation step of the intrinsic pathway. Experiments with both human and mouse plasmas have defined the specificity of the inhibitor as follows: (1) It lengthens the partia...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tsang VC,Damian RT

    更新日期:1977-04-01 00:00:00